News Releases

New "plus" version of test adds a 3rd gene target to enhance detection of future SARS-CoV-2 variants

PCRplus Tests Include Multi-Gene Targets

New "plus" version of test adds a 3rd gene target to enhance detection of future SARS-CoV-2 variants

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season

Four Viral Infections Have Similar Patient Presentations, Making Accurate Detection and Differentiation Critical During Next Flu Season

First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19

Enabling on-demand monitoring of BCR-ABL levels in patients with Chronic Myeloid Leukemia (CML)

On-Demand Same-Day Extragenital Testing for Chlamydia and Gonorrhea Fills Critical Unmet Need in Fight Against Rising Rates of Chlamydial and Gonorrheal Infection

SpeeDx is the First Trusted Reagent Manufacturer to launch a new test for use on the GeneXpert® System

Simplify Hepatitis B Treatment Management

Enables Hepatitis C Point-of-Care molecular testing and linkage to care

Respiratory Infection Results in as Little as 20 Minutes(1)

Xpert® Carba-R now FDA-cleared to aid clinicians in determining appropriate therapeutic strategy for pure colony specimens

Accurate and Reliable Group A Streptococcus Detection in as Little as 18 Minutes(1)

Updated guidelines reaffirm PCR as highly sensitive method for detecting deadly toxigenic C. difficile

Flu Results in as Little as 20 Minutes[1]

Accurate and Reliable Group A Strep Detection in as soon as 18 minutes(1)

Providing Rapid Molecular Diagnostic Results in as little as 20 minutes

Xpert® MRSA NxG Expands Strain Coverage to Address Evolving Threats

Why Choose Between Fast or Accurate When You Can Have Both?

Xpert Bladder Cancer Monitor Now Commercially Available

Binary Toxin Gene Reporting has Been Added to the Market Leading Xpert C. difficile Product

Enabling Accurate and Fast Molecular HIV Viral Load Test from Finger Stick Whole Blood

First and Only Trichomonas NAAT Test with Male Urine Claims Cleared for Use in United States

Xpert HPV Fulfills International Requirements for Use as Primary Screening Test

Hammersmith Broadway is Next in a Series of Clinics to Offer Fast and Discrete Testing.

Xpert Carba-R Test is the First FDA-Cleared Molecular Test for Rapid Detection of Carbapenemase Producing Organisms Directly from Rectal Swab Specimens

Broadens Access to Critical Diagnostic Results for Infants Born with HIV

Further Broadens Reach of GeneXpert System into Non-Acute Market in United States

Cepheid Highlights Role of Diagnostics as Valuable Tool in Growing Fight Against Antibiotic Resistance

The Number One, On-Demand Molecular Test for MRSA Colonization is Now Improved

Xpert Carba-R Results in Less Than an Hour Help to Prevent and Manage Outbreaks

Dean Street Express Expanding to Additional Locations using GeneXpert Infinity System

Commercial Clinical Grew 19%, or 21% in Constant Currency, Driven by Record Reagent Revenue and Record GeneXpert System Placements

GeneXpert Systems and Xpert Tests Expected to Enhance Efficiency of Clinical Trials

Announces Preliminary Q415 Revenue of Approximately $147 Million

Xpert BCR-ABL Ultra Assesses Deep Molecular Response in Chronic Myeloid Leukemia Patients on Treatment with Tyrosine Kinase Inhibitors

Reference Laboratory Test Performance at the Point of Care

Named as a Supplier to the Global Fund for HIV Diagnostics

Initiates 2016 Revenue Outlook and Discusses 2017 Targets

Broad Xpert Test Menu Targets Appropriate Antibiotic Management Initiatives

Commercial Clinical Growth of 22% for First Nine Months of 2015

Xpert Carba-R Detects and Differentiates Most Prevalent CROs

GeneXpert Omni to Further Decentralize Critical TB, Virology and Ebola Tests

GeneXpert Omni Sets New Standard for Molecular Point of Care Testing

Commercial Clinical Grows 24%

Xpert Ebola listed in World Health Organization Emergency Use Assessment and Listing program for diagnostic products in the context of global health emergency

Commercial Clinical Reagents Grow 35%

Qualitative 90-Minute Test Enables Early HIV Detection in High-Risk and Pediatric Patients

Quantitative Test for Rapid Measurement of Hepatitis C virus Viral Load and confirmation of HCV infection delivers on-demand results in less than 2 hours